URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


6th Antigen-Specific Immune Tolerance Summit | Boston, MA | February 27 - March 01, 2023


Date
Feb 27, 2023 - 08:00 AM - Mar 01, 03:00 PM
Organizer
Hanson Wade
Venue
Embassy Suites by Hilton Boston at Logan Airport
Location
207, Porter St

Boston,
MA,
USA,
ZIP: 02128
Phone:

Ticket Price: USD 2199.00 - USD 6046.00

The 6th Antigen-Specific Immune Tolerance Summit returns as the definitive industry-dedicated forum bringing you the latest discoveries, preclinical, translational, and early clinical developments on tolerogenic therapies.  

Immune tolerance is not only the most dramatic and therapeutically advantageous approach in the industry's arsenal against autoimmunity; it is also transforming the biologic and gene therapy landscape through reducing ADA formation and paving the way for the industry to make multiple, lower doses while achieving greater effects.  

Molecular mechanisms underlying tolerance induction are yet to be elucidated, and the clinical challenges have highlighted the need to overcome the translational obstacles the space is facing. Meanwhile, ongoing investment and collaboration continues, and the space is filled with excitement as many start-ups are developing immune-tolerance tools based on cell therapies and immune-modifying nanoparticles.  

Attending this unique summit will allow you to meet 80+ industry leaders and:  

Delve into and tackle complex heterogenous diseases with multiple antigens and epitopes 

Explore the breadth of novel technologies and platforms for antigen delivery and navigate frequency of administration to transform tolerance strategies 

Investigate clinical endpoints and determinants of efficacy 

and much more...  

Don't miss this unique opportunity to hear from and connect with drug developers and researchers supercharging life-changing and ground-breaking antigen-specific immunotherapies into the clinic and to patients in need.  

URLs:
Tickets: https://go.evvnt.com/1422186-2?pid=1052
Brochure: https://go.evvnt.com/1422186-3?pid=1052

Prices:
Industry Pricing - Conference + 3 Workshops: USD 4946.00,
Industry Pricing - Conference + 2 Workshops: USD 4297.00,
Industry Pricing - Conference + 1 Workshop: USD 3648.00,
Industry Pricing - Conference Only: USD 2999.00,
Academic Pricing - Conference + 3 Workshops: USD 3246.00,
Academic Pricing - Conference + 2 Workshops: USD 2897.00,
Academic Pricing - Conference + 1 Workshop: USD 2548.00,
Academic Pricing - Conference Only: USD 2199.00,
Solution Provider Pricing - Conference + 3 Workshops: USD 6046.00,
Solution Provider Pricing - Conference Only: USD 2899.00

Speakers: Aaron Winkler, Research Fellow, Immune Tolerance Lead, Pfizer, Antoon van Oosterhout, Chief Scientific Officer and Vice President - Research and Development, Imcyse, Arpita Maiti, Head of Immunology - Search and Evaluation, AbbVie, Betty Diamond, Professor, Feinstein Institute for Medical Research, Brendan Classon, Executive Vice President - Clinical and Translational Development, Parvus Therapeutics, Bruna Barneda, Director - Preclinical and Clinical Development, Ahead Therapeutics, Charlotte Fribert, Chief Executive Officer, Toleranzia, Daniel Lagassé, Biologist, FDA CBER, David Fox, Professor - Rheumatology and Internal Medicine, Immune Tolerance Network, Fred Ramsdell, Chief Scientific Officer and Co-Founder, Sonoma Biotherapeutics, Georg Schett, Vice President - Research and Professor,  Friedrich-Alexander-Universität Erlangen-Nürnberg, Glennda Smithson, Senior Director - Head of Celiac Discovery and Biomarkers, Takeda, Heather Denroche, Director, Preclinical Development, Integrated Nanotherapeutics Inc., Hidde Ploegh, Professor, Boston Children's Hospital, José Carballido, Executive Director - Translational Medicine and Preclinical Safety, Novartis, Kei Kishimoto, Chief Scientific Officer, Selecta Bio, Kristie Grebe, Senior Vice President - Immunology and Translational Development, Anokion, Leonard Dragone, Chief Medical Officer, Sonoma Biotherapeutics, Markus Ollert, Director - Infection and Immunity Department, Luxembourg Institute of Health, Matthias von Herrath, Vice President and Senior Medical Officer, Novo Nordisk, Michael Boyne, Vice President of Product Development, Cour Pharmaceutical Development Company, Pankaj Gupta, Director, Search and Evaluation Lead, Inflammation and Immunology, Pfizer, Poul Sorensen, Co-founder and Chief Scientific Officer, Allero Therapeutics, Stefano Vavassori, Head of Immunology, Cellerys, Stephen Miller, Professor Emeritus of Microbiology- Immunology, Northwestern University, Ulf Hannelius, President and Chief Executive Officer, Diamyd Medical

Event Categories
Keywords: Health , Conferences




Comments








Events Calendar

SunMonTueWedThuFriSat
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 1 2 3 4

Event Location

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99